Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | MAP3K6 |
| Upstream (Parents) |
|---|
| (<<) AKT3 → MAP3K6 |
| (<<) ANGPTL4 → MAP3K6 |
| (<<) CASP4 → MAP3K6 |
| (<<) CCNL1 → MAP3K6 |
| (<<) DUSP6 → MAP3K6 |
| (<<) DVL1 → MAP3K6 |
| (<<) HSP90AA1 → MAP3K6 |
| (<<) IGFBP4 → MAP3K6 |
| (<<) PIK3R5 → MAP3K6 |
| (<<) PLCB3 → MAP3K6 |
| (<<) PRKCZ → MAP3K6 |
| (<<) PTRF → MAP3K6 |
| (<<) RAD51L3 → MAP3K6 |
| (<<) RECK → MAP3K6 |
| (<<) SYNPO → MAP3K6 |
| (<<) TYK2 → MAP3K6 |
| Downstream (Children) |
|---|
| MAP3K6 → BMPR1A (>>) |
| MAP3K6 → BRCA1 (>>) |
| MAP3K6 → CDK6 (>>) |
| MAP3K6 → DDX21 (>>) |
| MAP3K6 → DNM2 (>>) |
| MAP3K6 → DUSP4 (>>) |
| MAP3K6 → EFEMP1 (>>) |
| MAP3K6 → EML4 (>>) |
| MAP3K6 → GNA13 (>>) |
| MAP3K6 → GNAQ (>>) |
| MAP3K6 → GPR153 (>>) |
| MAP3K6 → GSTK1 (>>) |
| MAP3K6 → KHDRBS3 (>>) |
| MAP3K6 → LAMB2 (>>) |
| MAP3K6 → LRP6 (>>) |
| MAP3K6 → MAN2A2 (>>) |
| MAP3K6 → MAPK7 (>>) |
| MAP3K6 → MEGF6 (>>) |
| MAP3K6 → N4BP3 (>>) |
| MAP3K6 → NOL9 (>>) |
| MAP3K6 → PLA2G3 (>>) |
| MAP3K6 → PPRC1 (>>) |
| MAP3K6 → RARG (>>) |
| MAP3K6 → RCAN1 (>>) |
| MAP3K6 → RPL36 (>>) |
| MAP3K6 → SHFM1 (>>) |
| MAP3K6 → SQLE (>>) |
| MAP3K6 → STX12 (>>) |
| MAP3K6 → TMEM39B (>>) |
| MAP3K6 → TNF (>>) |
